You may qualify if you have a BMI of 30 or higher, or 27+ with weight-related conditions
Retatrutide is an investigational compound that is not FDA approved and is available only as a compounded research peptide
Nausea can occur but is easily treated
Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A (2015) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
The brand's positioning is that it delivers added value through coaching, supplement access, and active lifestyle integration - whether that matches your needs depends on your situation
These include enhanced cardiovascular health, better blood sugar management, reduced joint pain, increased mobility and energy, improved sleep, and greater self-confidence